← Leaderboards
Yvonne J Paterson
University Of Pennsylvania
$19,301,697
Attributed
$19,301,697
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–14$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$19,301,697 · 8
By mechanism
K12$6,491,978 · 1
T32$6,076,680 · 1
R01$5,854,015 · 3
R41$506,452 · 2
R21$372,572 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Warren S Pear$28,448,095
- Steven J Siegel$10,032,755
- Benhur Lee$26,036,912
- Gary H Cohen$11,413,390
- Harvey Rubin$4,989,296
Others in their field
Top investigators on “Tumor Antigens”
- William R Green · Dartmouth College$32,738,211
- John H Sampson · Duke University$30,849,602
- Catherine Ju-Ying Wu · Broad Institute, Inc.$30,485,072
- Elizabeth Marion Jaffee · Johns Hopkins University$26,862,085
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$24,066,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Research focus
Tumor AntigensChimeric ProteinsVector VaccineListeriaFundingDendritic CellsProgramsThyroglobulinLaboratory MouseHuman PapillomavirusBacterial ProteinsVirus ProteinLifeHuman Papillomavirus 16GenesListeria MonocytogenesImmunogenicImmune ToleranceBaseImmunityAntigensImmunogenicityCellsBacteria
Grant awards (45)
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching$798,876
K12 · FY2014 · GM · contact PI
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching$745,908
K12 · FY2013 · GM · contact PI
University of Pennsylvania Postdoctoral Opportunities in Research and Teaching$925,977
K12 · FY2012 · GM · contact PI
Institutional Research and Academic Career Development Award$852,196
K12 · FY2011 · GM · contact PI
Cancer immunotherapy with a live recombinant vaccine$317,115
R01 · FY2011 · CA · contact PI
Institutional Research and Academic Career Development Award$949,712
K12 · FY2010 · GM · contact PI
Cancer immunotherapy with a live recombinant vaccine$326,923
R01 · FY2010 · CA · contact PI
Immunotherapeutic strategies for breast cancer$239,594
R01 · FY2010 · CA · contact PI
Institutional Research and Academic Career Development Award$949,817
K12 · FY2009 · GM · contact PI
Immunobiology of normal and neoplastic lymphocytes$651,130
T32 · FY2009 · CA · contact PI
Cancer immunotherapy with a live recombinant vaccine$326,923
R01 · FY2009 · CA · contact PI
Immunotherapeutic strategies for breast cancer$239,732
R01 · FY2009 · CA · contact PI
Institutional Research and Academic Career Development Award$132,662
K12 · FY2009 · GM · contact PI
Cancer immunotherapy with a live recombinant vaccine$13,929
R01 · FY2009 · CA · contact PI
Institutional Research and Academic Career Development Award$682,949
K12 · FY2008 · GM · contact PI
Immunobiology of normal and neoplastic lymphocytes$647,893
T32 · FY2008 · CA · contact PI
Cancer immunotherapy with a live recombinant vaccine$326,923
R01 · FY2008 · CA · contact PI
Immunotherapeutic strategies for breast cancer$239,865
R01 · FY2008 · CA · contact PI
Cancer immunotherapy with a live recombinant vaccine$41,786
R01 · FY2008 · CA · contact PI
Immunobiology of normal and neoplastic lymphocytes$656,015
T32 · FY2007 · CA · contact PI
Institutional Research and Academic Career Development Award$453,881
K12 · FY2007 · GM · contact PI
Cancer immunotherapy with a live recombinant vaccine$326,923
R01 · FY2007 · CA · contact PI
Immunotherapeutic strategies for breast cancer$239,995
R01 · FY2007 · CA · contact PI
Immunobiology of normal and neoplastic lymphocytes$653,908
T32 · FY2006 · CA · contact PI
Enhancing the immunogenicity of idiotypes for therapy of Non-Hodgkin's lymphoma$250,063
R41 · FY2006 · CA · contact PI
Immunotherapeutic strategies for breast cancer$247,292
R01 · FY2006 · CA · contact PI
Immunobiology of normal and neoplastic lymphocytes$628,600
T32 · FY2005 · CA
Bacterial vector vaccine: Her-2/neu expressing tumors$256,389
R41 · FY2005 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES$624,495
T32 · FY2004 · CA
Immunogenicity of HIV proteins delivered by live vector$372,572
R21 · FY2004 · AI
Cancer Immunotherapy with a Live Recombinant Vaccine$322,548
R01 · FY2004 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$72,910
R01 · FY2004 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES$649,568
T32 · FY2003 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$322,548
R01 · FY2003 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$72,910
R01 · FY2003 · CA
IMMUNOGENICITY OF HIV PROTEINS DELIVERED BY LIVE VECTOR$577,155
R01 · FY2002 · AI
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES$553,518
T32 · FY2002 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$249,638
R01 · FY2002 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$72,910
R01 · FY2002 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$51,777
R01 · FY2002 · CA
IMMUNOGENICITY OF HIV PROTEINS DELIVERED BY LIVE VECTOR$493,682
R01 · FY2001 · AI
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES$427,780
T32 · FY2001 · CA
Cancer Immunotherapy with a Live Recombinant Vaccine$249,638
R01 · FY2001 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES$583,773
T32 · FY2000 · CA
IMMUNOGENICITY OF HIV PROTEINS DELIVERED BY LIVE VECTOR$481,299
R01 · FY2000 · AI